Citizens JMP analyst Jonathan Wolleben reiterated a Market Perform rating and {REMOVEPT} price target on Spruce Biosciences, Inc. (NASDAQ: SPRB).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE